KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$4.9 million.

  • Fulgent Genetics' Change in Receivables fell 40958.99% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year increase of 15896.65%. This contributed to the annual value of $16.3 million for FY2024, which is 78270.52% up from last year.
  • As of Q3 2025, Fulgent Genetics' Change in Receivables stood at -$4.9 million, which was down 40958.99% from $8.3 million recorded in Q2 2025.
  • Fulgent Genetics' Change in Receivables' 5-year high stood at $34.6 million during Q1 2021, with a 5-year trough of -$67.1 million in Q2 2021.
  • In the last 5 years, Fulgent Genetics' Change in Receivables had a median value of $1.6 million in 2024 and averaged -$4.7 million.
  • Over the last 5 years, Fulgent Genetics' Change in Receivables had its largest YoY gain of 3336442.31% in 2021, and its largest YoY loss of 98920.57% in 2021.
  • Quarter analysis of 5 years shows Fulgent Genetics' Change in Receivables stood at $22.7 million in 2021, then plummeted by 295.67% to -$44.4 million in 2022, then soared by 111.72% to $5.2 million in 2023, then skyrocketed by 155.86% to $13.3 million in 2024, then tumbled by 136.83% to -$4.9 million in 2025.
  • Its last three reported values are -$4.9 million in Q3 2025, $8.3 million for Q2 2025, and $4.5 million during Q1 2025.